Whooping cough booster study shows strong immune response in south african kids
NCT ID NCT04300192
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tested a Tdap-IPV booster vaccine in 273 children in South Africa to see how their immune systems responded based on the whooping cough vaccine they received as infants. Researchers measured antibody levels and cell-mediated immunity over time. The goal was to understand if the type of vaccine given in early childhood affects the booster's effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS IMMUNISATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 7100001
Cape Town, 7925, South Africa
-
Investigational Site Number : 7100002
Middelburg, 1055, South Africa
-
Investigational Site Number : 7100003
Johannesburg, 1619, South Africa
Conditions
Explore the condition pages connected to this study.